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Background: There is growing evidence that fish protein hydrolysate (FPH) diets affect mitochondrial fatty acid
metabolism in animals. The aim of the study was to determine if FPH could influence fatty acid metabolism and
inflammation in transgene mice expressing human tumor necrosis factor alpha (hTNFα).
Methods: hTNFα mice (C57BL/6 hTNFα) were given a high-fat (23%, w/w) diet containing 20% casein (control
group) or 15% FPH and 5% casein (FPH group) for two weeks. After an overnight fast, blood, adipose tissue, and
liver samples were collected. Gene expression and enzyme activity was analysed in liver, fatty acid composition was
analyzed in liver and ovarian white adipose tissue, and inflammatory parameters, carnitine, and acylcarnitines were
analyzed in plasma.
Results: The n-3/n-6 fatty acid ratio was higher in mice fed the FPH diet than in mice fed the control diet in both
adipose tissue and liver, and the FPH diet affected the gene expression of Δ6 and Δ9 desaturases. Mice fed this diet
also demonstrated lower hepatic activity of fatty acid synthase. Concomitantly, a lower plasma INF-γ level was
observed. Plasma carnitine and the carnitine precursor γ-butyrobetaine was higher in the FPH-group compared to
control, as was plasma short-chained and medium-chained acylcarnitine esters. The higher level of plasma
acetylcarnitine may reflect a stimulated mitochondrial and peroxisomal β-oxidation of fatty acids, as the hepatic
activities of peroxisomal acyl-CoA oxidase 1 and mitochondrial carnitine palmitoyltransferase-II were higher in the
FPH-fed mice.
Conclusions: The FPH diet was shown to influence hepatic fatty acid metabolism and fatty acid composition. This
indicates that effects on fatty acid metabolism are important for the bioactivity of protein hydrolysates of marine origin.
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Dietary proteins and the bioactive peptides generated
from proteins, either formed naturally in the gut or de-
livered in the diet as hydrolyzed proteins, may have a
number of important effects beyond their role as sources
of amino acids and energy [1]. Studies on fish peptides
have demonstrated antihypertensive [2-5], antioxidant
[6-9], and immunomodulating effects [10], as well as* Correspondence: bodil.bjorndal@k2.uib.no
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reproduction in any medium, provided the orreparative properties in the intestine [11,12]. Hydrolyzed
proteins from plant and fish have been demonstrated to
alter the cholesterol and lipid metabolism in rodent
studies, and to reduce plasma cholesterol and triglycer-
ide levels [1,13-15]. In addition, we previously found a
reduction in hepatic Δ5 and Δ6 desaturase mRNA ex-
pression in obese Zucker rats by a fish protein hydrolys-
ate (FPH) diet [16].
There is an inter-organ transport of fatty acids, and major
tissues in fatty acid metabolism from an energy point of
view are the gut, white adipose tissue (WAT), liver andl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Fasting lipid levels in TNFα mice given a control-
or a FPH-high-fat diet for two weeks
Plasma lipids Hepatic lipids
Treatment Control FPH Control FPH
(mmol/L) (mmol/L) (μmol/g liver) (μmol/g liver)
Cholesterol 1.74 ± 0.18 1.71 ± 0.18 8.2 ± 1.3 7.7 ± 0.8
Triacylglycerol 0.50 ± 0.15 0.58 ± 0.10 25.3 ± 2.8 29.3 ± 4.6
Phospholipids 1.67 ± 0.23 1.66 ± 0.14 18.9 ± 0.78 19.0 ± 0.52
Abbreviations: FPH fish protein hydrolysate, TNFα tumor necrosis factor alpha.
Mean values ± SD are shown (n = 5).
Mann–Whitney analysis (p < 0.05) was used to determine if values were
significantly different from control.
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elongation processes that determine the fatty acid compos-
ition during de novo lipogenesis. Studies have indicated that
diet-induced alterations in the membrane phospholipid
composition has important effects on inflammation, in par-
ticular through increased anti-inflammatory prostaglandin
and resolvine production from n-3 polyunsaturated fatty
acids (PUFAs) [17]. The Δ9 desaturase steroyl-CoA
desaturase 1 (SCD1) is important for the generation of
monounsaturated fatty acids during lipogenesis. It plays a
role in inflammatory regulation, and its upregulation is
correlated to many metabolic diseases including obesity
and insulin resistance [18,19]. Previous studies indicate
that dietary protein composition plays an important role
in the regulation of fatty acid desaturation as well as cho-
lesterol metabolism [14,20,21]. Thus, protein hydrolysate
diets could potentially target lipogenesis and desaturation
and thereby positively influence metabolic disturbances.
As hydrolyzed proteins have the ability to modulate
both lipid metabolism, and inflammation processes, we
investigated in the present study whether a 15% FPH diet
high in glycine and taurine could counteract the effects
of tumor necrosis factor alpha (TNFα) overexpression.
Mice transgenic for human TNFα (hTNFα) have previ-
ously been shown to display dyslipidemia, altered lipid
composition, and reduced activation of peroxisome
proliferator-activated receptor alpha (PPARα) regulated
genes [22]. In the present study, we show that the admin-
istration of FPH to hTNFα mice fed a high-fat diet af-
fected fatty acid composition in liver and WAT with a
concurrent increase in the fatty acid anti-inflammatory
index. In addition, plasma carnitine and short-chained
acylcarnitine esters, and hepatic peroxisomal fatty acid
oxidation were increased, while lipogenesis was reduced.
Results
The effect of FPH on feed intake and blood lipids
TNFα-mice were fed high-fat diets with or without 15%
FPH for two weeks. No changes were observed in fasting
plasma or hepatic lipid levels (Table 1). There was a sig-
nificantly higher weight gain, but no difference in feed
efficiency in the FPH-group compared to control after
two weeks feeding. Feed intake was higher in the FPH-
group, and this could have caused the higher weight gain
compared to control (Table 2).
Fatty acid composition in liver and WAT
The relative amounts of saturated fatty acids were higher in
the ovarian WAT of TNFα-transgene mice fed FPH and
this was due to an elevated level of C18:0 (Table 3). The
total level of saturated fatty acids in the liver was un-
affected, but a higher level of C16:0 was found after FPH
feeding compared to control. The level of the monounsatu-
rated fatty acid C18:1n-7 was lower both in liver and WATin FPH-fed mice compared to control. This resulted in a
lower elongase index (Figure 1a). Of the n-6 fatty acids,
most were significantly lower in the liver of mice adminis-
tered with FPH-diet, whereas hepatic C18:2n-6 was higher,
giving no effect on total n-6 PUFA. The total hepatic level
of n-3 fatty acid was greater in FPH-fed mice than in con-
trol TNFα mice. Significantly higher levels of EPA (C20:5n-
3) and DPA (C22:5n-3) were found in both liver and WAT.
In addition, the level of C18:3n-3 and C22:6n-3 was higher
in the liver after FPH-feeding compared to casein-feeding.
Altogether, the n-3 index was elevated in both liver and
WAT after FPH administration (Figure 1b), as well as the
Δ5 desaturase index for n-3 fatty acids and Δ6 desaturase
index for n-3 fatty acids (Figure 1c and d). However, the
hepatic Δ6 desaturase (Fads2) was significantly lower
expressed at the gene level compared to control, while the
Δ5 desaturase (Fads1) was insignificantly changed (Figure 1e
and f).
Anti-inflammatory index and plasma cytokines
The fatty acid anti-inflammatory index was calculated
from the levels of the anti-inflammatory fatty acids
(C22:5n-3 + C22:6n-3 + C20:3n-6 + C20:5n-3) and the pre-
inflammatory fatty acid arachidonic acid (C20:4n-6),
and was found to be elevated both in liver and WAT
after FPH-treatment (Figure 2a). In addition, the plasma
level of interferon gamma (INFγ) was significantly de-
creased by the FPH diet compared to control (P = 0.0061)
(Figure 2b). Interleukine-1 beta (IL-ib), IL-2, IL-5, and
GM-CSF were not significantly different in FPH vs. con-
trol, nor were plasma adiponectin levels (Figure 2c-g).
Hepatic fatty acid oxidation and synthesis
The differences in fatty acid composition could be due not
only to changes of the desaturases, but also enhanced
mitochondrial and peroxiosmal fatty acid oxidation or
synthesis in mice fed different diets. Both the hepatic ac-
tivities of carnitine palmitoyltransferase II (CPT-II) and
acyl-CoA-oxidase 1 (ACOX1), involved in mitochondrial
and peroxisomal b-oxidation, respectively, were signifi-
cantly higher in mice given the FPH diet (Figure 3a and
Table 2 Weight gain and feed intake in TNFα mice given
control- or FPH-diets for two weeks
Treatment Weight
gain1 (g)
Feed
intake2 (g)
Feed efficiency
(weight gain/feed intake)
Control 1.40 ± 0.55 34.2 0.041 ± 0.016
FPH 2.60 ± 0.89* 38.6 0.067 ± 0.023
Abbreviations: FPH fish protein hydrolysate, TNFα tumor necrosis factor alpha.
1Mean values ± SD are shown (n = 5).
2Total feed intake in 14 days calculated per mouse is shown.
*indicates significantly different from control (Mann–Whitney, p < 0.05).
Significance could not be calculated for the feed intake.
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In addition, fatty acid synthesis, measured as fatty acid
synthase (FAS) activity, was significantly lower in the FPH
group compared to the control group (Figure 3c).
On the mRNA level, no changes were observed in genes
involved in β-oxidation (Cpt1a, Cpt2, Acox1 or Hadha,
Figure 4a-d), or in the release of fatty acids from TAG
(arylacetamide deacetylase (Aadac), Figure 4e). However,
HMG-CoA synthase 2 (Hmgcs2) gene expression was sig-
nificantly higher in the FPH group compared to control
(Figure 4f). The rate-limiting enzyme in fatty acid synthesis,
acetyl-CoA carboxylase alpha (ACC), was not expressed
differently at the mRNA-level (Acaca, Figure 4g), but the
Δ9 desaturase (Scd1) was significantly lower in FPH treated
mice (Figure 4h). The SCD1 index, based on the ratioTable 3 Fatty acid composition in liver and WAT of mice give
Fatty acids % (w/w) Liver
Control
∑ SFAs 34.57 ± 0.74 34.8
C16:0 21.42 ± 0.35 22.1
C18:0 12.02 ± 0.55 11.4
∑ MUFAs 25.43 ± 0.89 24.2
C16:1n-7 1.03 ± 0.13 1.03
C18:1n-7 1.60 ± 0.08 1.32
C18:1n-9 21.77 ± 0.75 21.0
∑ n-6 PUFAs 31.05 ± 0.59 30.5
C18:2n-6 16.00 ± 0.54 17.0
C20:3n-6 0.90 ± 0.06 0.76
C20:4n-6 12.96 ± 0.79 11.7
C22:4n-6 0.34 ± 0.01 0.25
∑ n-3 PUFAs 8.73 ± 0.65 10.24
C18:3n-3 0.42 ± 0.03 0.50
C20:5n-3 (EPA) 0.29 ± 0.03 0.57
C22:5n-3 0.29 ± 0.02 0.42
C22:6n-3 (DHA) 7.60 ± 0.65 8.60
∑ n-3:∑ n-6 ratio 0.28 ± 0.35 0.34
Abbreviations: DHA docosahexaenoic acid, EPA eicosapentaenoic acid, FPH fish prote
acids, SFA saturated fatty acids, WAT white adipose tissue.
Data are means ± SD (n = 5). Values significantly different from control are indicatedbetween the SCD1-product and -substrate (C18:1n-9/
C18:0), was significantly lower in FPH-fed mice only in
WAT (Figure 4i), while C16:1n-7:C16:0 was unchanged
(not shown). Neither selected genes involved in choles-
terol synthesis and bile formation (Hmgcs1 and Cyp7a1,
respectively), nor genes involved in fatty acid- or low-
density lipoprotein-import (CD36 and low-density lipo-
protein receptor (Ldlr), respectively) were affected by the
FPH diet (Figure 5).
Precursor of carnitine and carnitine esters in plasma
Carnitine is necessary to transport CoA-activated fatty
acid into the mitochondria and out of the peroxisomes. It
was of interest that both carnitine itself (Figure 6a) and
the precursor of carnitine, γ-butyrobetaine (Figure 6b)
were found at higher levels in plasma of FPH-fed mice
compared to control-diet fed mice. Moreover, a higher
level of acetylcarnitine (Figure 6c) was observed, and a
small but significantly higher level of octanoylcarnitine
(Figure 6d). Plasma levels of propionylcarnitine and pal-
mitoylcarnitine were not significantly different between
groups (Figure 6e and f).
Discussion
Several investigations have reported an effect of inflam-
matory cytokines on lipid metabolism [23-26]. The targetn control- or FPH-diets for 2 weeks and fasted over night
WAT
FPH Control FPH
1 ± 0.87 32.35 ± 1.08 34.35 ± 1.15*
9 ± 0.49* 25.26 ± 0.83 26.13 ± 1.31
9 ± 0.57 4.61 ± 0.45 5.73 ± 0.55**
5 ± 1.31 48.62 ± 1.17 47.83 ± 2.35
± 0.12 4.74 ± 0.34 4.51 ± 0.46
± 0.09*** 2.22 ± 0.08 2.04 ± 0.04**
1 ± 1.15 40.35 ± 1.40 40.08 ± 5.53
2 ± 0.07 17.61 ± 1.38 16.21 ± 1.35
3 ± 0.75* 16.70 ± 1.41 15.38 ± 1.30
± 0.05** 0.15 ± 0.01 0.12 ± 0.01*
9 ± 0.57* 0.34 ± 0.04 0.30 ± 0.04
± 0.01*** 0.07 ± 0.01 0.06 ± 0.01*
± 0.68** 1.28 ± 0.10 1.49 ± 0.25
± 0.05* 0.89 ± 0.06 0.98 ± 0.14
± 0.10*** 0.03 ± 0.01 0.06 ± 0.02**
± 0.02*** 0.07 ± 0.01 0.09 ± 0.02*
± 0.60* 0.24 ± 0.03 0.32 ± 0.07
± 0.02** 0.07 ± 0.01 0.09 ± 0.01**
in hydrolysate, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty
(*P < 0.05,**P < 0.01,***P < 0.001).
Figure 1 The effect of fish protein hydrolysate on hepatic and white adipose tissue fatty acid composition. hTNFα transgenic mice were
given a 15% (w/w) fish protein hydrolysate (FPH) diet for two weeks, fasted over night, and fatty acid composition (wt%) was determined in liver
and white adipose tissue (WAT), and gene expression was determined in liver. Elongase activity was calculated as an indirect index based on the
n-3 PUFAs C20:3n-6/C18:3n-6 (a). The omega-3 index was based on the sum of EPA (C20:5n-3) and DHA (C22:6n-3) (b). An indirect index of Δ5
desaturase activity based on n-3 PUFAs was calculated as C20:5n-3/C20:4n-3 (c). An indirect index of Δ6 desaturase activity based on n-3 PUFAs
was calculated as C18:4n-3/C18:3n-3 (d). Hepatic gene expression of D6 desaturase (Fads2) (e). Hepatic gene expression of D5 desaturase (Fads1)
(f). Data are means ± SD (n = 5) of control (white bars) and FPH (grey bars). Values significantly different from control are indicated (*P < 0.05,
**P < 0.01, ***P < 0.001).
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ing the fasting response, were downregulated in the liver of
TNFα overexpressing mice [22]. As PPARα regulates both
the lipid- and amino acid metabolism, we have in the
present study investigated whether an FPH-diet can coun-
teract TNFα-induced metabolic aberrations. We observed
a significant effect on the hepatic and WAT fatty acid com-
position of FPH-fed mice, linked to effects on the gene ex-
pression or activity of genes involved in desaturation and
lipogenesis. This demonstrates that casein- and salmon de-
rived sources of protein differentially influence lipid metab-
olism in hTNFα mice.The higher activity of CPT-II and ACOX1 accompanied
with higher plasma levels of short-and medium carnitine
esters in mice fed FPH suggest that this diet was able to
improve the hepatic fatty acid oxidation capacities com-
pared to a casein diet. Acetyl-CoA could potentially be
used for keton body production, as the gene expression of
the mitochondrial HMG-CoA synthase was upregulated.
Alternatively, the observed higher level of plasma L-
carnitine in FPH-fed mice could facilitate mitochondrial
efflux of β-oxidation products. L-carnitine supplementa-
tion has previously been shown to relieve lipid overload
and increase glucose sensitivity in obese mice [27].
Figure 2 A fish protein hydrolysate diet affected inflammation in TNFα mice. hTNFα transgenic mice were given a 15% (w/w) fish protein
hydrolysate (FPH) diet for two weeks and fasted over night. The anti-inflammatory index (n = 5) was calculated from wt% of fatty acids ((C22:5n-3 +
C22:6n-3 + C20:3n-6 + C20:5n-3)/C20:4n-6)*100 (a). The plasma level of INFγ (b), IL-1b (c), IL-2 (d), IL-5 (e), GM-CFS (f), and adiponectin (g) was
determined (n = 4–5) . Data are given as means ± SD, and values significantly different from control are indicated (**P < 0.01).
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to casein diets have previously been observed in rodents,
and may be due to decreased intestinal absorption con-
comitant with increased hepatic excretion of cholesterol
and bile [28,29]. FPH has in some rodent studies also
resulted in lower plasma triacylglycerol (TAG) levels
[15,30]. It was therefore of importance to note that in this
study FPH did not reduce plasma cholesterol or TAG
levels. The reason for this is not clear, but one possibility
is that the mitochondrial CPT-II activity was marginally
higher with FPH mice than in control mice (20%) and that
no significantly elevated gene expression of the PPARα ac-
tivated genes Cpt1a, Cpt2, nor Hadha were observed. The
observed lower lipogenesis with FPH vs. casein, similar to
observations with vegetable protein diets in rats [13], wasFigure 3 The effect of fish protein hydrolysate on hepatic enzyme ac
hydrolysate (FPH) diet for two weeks, and the hepatic enzyme activities of
(ACOX1) (b), and fatty acid synthase (FASN) (c) was measured. Data are giv
control are indicated (*P < 0.05, **P < 0.01, ***P < 0.001).not sufficient to lower plasma TAG levels (Figure 3c).
Also, no effect was seen on genes involved in cholesterol
and bile production. It might be that a longer feeding
period than two weeks is required to get a more pro-
nounced effect on mitochondrial fatty acid oxidation and
thereby overcome the hypertriglyceridemia in the TNFα
mice. Indeed, in another experiment with male C57BL/6
normolipidemic mice treated for 6 weeks, the plasma
TAG concentration was 28% lower in 15% FPH fed mice
than in casein fed mice, while cholesterol was unchanged
(RK Berge, data to be published). Interestingly, the male
mice gained less weight with a higher feed intake than the
control group, while in the current study the female FPH
mice gained more weight than control mice. This might
indicate sex-specific effects of FPH.tivity. hTNFα transgenic mice were given a 15% (w/w) fish protein
carnitine palmitoyl transferase-II (CPT-II) (a), acyl-CoA oxidase 1
en as means ± SD (n = 5), and values significantly different from
Figure 4 The effect of fish protein hydrolysate on hepatic genes involved in fatty acid metabolism. hTNFα transgenic mice were given
a 15% (w/w) fish protein hydrolysate (FPH) diet for two weeks, fasted over night, and the hepatic expression of selected genes was analyzed.
β-oxidation: carnitine palmitoyl transferase 1 (Cpt1a) (a), carnitine palmitoyl transferase 2 (Cpt2) (b), acyl-CoA oxidase 1 (Acox1) (c), trifunctional enzyme
(Hadha) (d). Ketogenesis: HMG-CoA synthase 2 (Hmgcs2) (e). Triacylglycerol lipase activity: arylacetamide deacetylase (Aadac) (f). Lipogenesis: acyl-coA
carboxylase (Acaca) (g), (steroyl-CoA desaturase 1 (Scd1) (h). An indirect index of hepatic and white adipose tissue (WAT) SCD1 activity was calculated as
C18:1n-9/C18:0 (i). Data are given as means ± SD (n = 5), and values significantly different from control are indicated (*P< 0.05, **P< 0.01, ***P< 0.001).
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position was different in the liver and WAT of mice fed
the FPH diet compared to the control diet, although the
diets did not differ substantially in fatty acid compos-
ition. In the liver this can at least partly be due to higher
mitochondrial and peroxisomal fatty acid oxidation. The
Δ5 and Δ6 fatty acid indices were higher in mice fed
FPH than casein, thus the changes in the fatty acid com-
position could also be due to differences in the activities
of Δ5 and Δ6 desaturases. The hepatic gene expression ofΔ6 desaturase was, however, lower than control whereas
the mRNA level of Δ5 desaturase was identical after FPH
administration. The lower gene expression levels could be
a negative regulatory response to a higher level of unsat-
urated fatty acids. This is in agreement with a previous
study demonstrating that in human WAT the gene ex-
pression of Δ5 and Δ6 desaturase was poorly reflected in
the corresponding indices [31]. In contrast, the different
SCD1 indices was linked to the gene expression level of
Scd1 [31]. Thus, the lower hepatic gene expression of
Figure 5 No effect of fish protein hydrolysate on hepatic genes involved in cholesterol metabolism and lipid transport. hTNFα
transgenic mice were given a 15% (w/w) fish protein hydrolysate (FPH) diet for two weeks, fasted over night, and the hepatic expression of
selected genes was analyzed: Cholesterol synthesis: HMG-CoA synthase 1 (Hmgcs1) (a). Bile production: Cyp7a1 (b). Fatty acid import: CD36
(c). Lipoprotein import: low-density lipoprotein receptor (Ldlr) (d). Data are given as means ± SD (n = 5), and values significantly different from
control are indicated (*P < 0.05, **P < 0.01, ***P < 0.001).
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plain the corresponding low SCD1-index in WAT from
FPH-mice. Interestingly, SCD1 has been shown to regu-
late inflammation and stress in several cell types [25].
Also, a low SCD1 expression level has been indicated to
protect against obesity and insulin resistance, while the
opposite is true for high SCD1 levels [18,19]. Particularly,
a high WAT 18:1/18:0 ratio has been linked to increased
probability of insulin resistance in older men [31]. Thus,
the observed reduction in the 18:1/18:0 ratio in WAT of
FPH-fed mice could indicate effects on fatty acid denatur-
ation beneficial to health.
As the FPH is a crude mix of hydrolysed peptides, fur-
ther isolation of active peptides is necessary to identify
the active component in this mix. There may also be an
influence by dietary EPA and DHA in the FPH group.
Analysis of the diets indicated only a small difference in
the n-3/n-6 PUFA ratio between the diets. However, the
EPA and DHA levels, although low, were increased in
the FPH compared to the control diet due to the 2%
remnant of fish oil in the protein hydrolysate (Table 4).
Thus to identify the protein-specific effects, the EPA and
DHA content should be kept constant in further studies.Conclusions
Treatment with FPH resulted in lower hepatic and WAT
levels of long-chain n-6 fatty acids compared to a casein
control. The anti-inflammatory fatty acid index was
thereby increased both in liver and WAT. As the plasma
level of INF-γ was reduced in the FPH-treated mice
while other cytokines measured were unchanged, FPH
may have an anti-inflammatory potential perhaps linked
to its effect on fatty acid metabolism. The main effect of
feeding TNFα mice a FPH diet was on fatty acid compos-
ition, lipogenesis, β-oxidation and acylcarnitines. This in-
dicates that regulation of lipid metabolism is important for
the bioactivity of protein hydrolysates of marine origin.
Methods
Transgenic mice
Female transgenic mice expressing human TNFα (hTNFα)
were used (Taconic, Germantown, USA). This mouse line
is generated in the strain C57BL/6, and express low levels
of hTNFα [32]. The experiments were performed in ac-
cordance with, and under the approval of, the Norwegian
State Board for Biological Experiments, the Guide for the
Care and Use of Laboratory Animals, and the Guidelines
Figure 6 A fish protein hydrolysate-diet increased plasma free carnitine, a carnitine precursor, and short-chained acylcarnitines. Fasting
plasma levels of free carnitine (a), γ-butyrobetaine (b), acetylcarnitine (c), propionylcarnitine (d), octanoylcarnitine (e), and palmitoylcarnitine
(f) after two weeks fish protein hydrolysate (FPH) treatment. Data are given as means ± SD (n = 5), and values significantly different from control
are indicated (*P < 0.05, **P < 0.01, ***P < 0.001).
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two experimental groups of five animals each with com-
parable mean body weight and were housed five animals
per cage under constant temperature (22 ± 2°C) and hu-
midity (55 ± 5%). They were exposed to a 12 h light–dark
cycle (light from 07.00 to 19.00) and had unrestricted ac-
cess to tap water and food. The mice were acclimatized to
these conditions for one week before the start of the
experiment.
Protein and fat of the feeding diets were from casein so-
dium salt from bovine milk, 20% w/w (Sigma-Aldrich
Norway AS, Oslo, Norway), and lard, 21% w/w (Ten Kate
Vetten BV, Musselkanaal, Netherlands), plus soy oil, 2%
w/w (Dyets Inc., Bethlehem, PA, USA). In addition, in
the intervention group part of the casein protein was
substituted by fish protein hydrolysate obtained from Atlan-
tic salmon (FPH, 15% w/w, supplied by Marine BioproductsAS, Storebø, Norway) (Table 5). The n-3 PUFA/n-6 PUFA
was similar in the two diets; however the EPA and DHA
amount was 5 and 4 times higher, respectively, indicating
an influence of the 2% fish oil in the FPH diet (Table 4).
After two weeks of feeding, the mice were anaesthetized
under over night fasting conditions by inhalation of 2%
isoflurane (Schering-Plough, Kent, UK). Blood was collected
by aortic puncture with 7.5% EDTA and immediately
chilled on ice. Plasma was prepared and stored at −80°C
prior to analysis. Ovarian WAT and liver were dissected,
immediately N2-cryo freeze-clamped and stored at −80°C.
Plasma and hepatic lipids
Liver lipids were extracted according to Blight and Dyer
[33], evaporated under nitrogen and redissolved in isopro-
panol before analysis. Lipids were measured enzymatically
in plasma samples and hepatic extracts on a Hitachi 917
Table 4 Amino acid composition, fatty acid composition,
and vitamin D content of the experimental diets
Diet groups Control (wt%)a FPH (wt%)
Amino acids:
ALA 3.01 6.97
ARG 3.14 5.23
ASP 7.27 8.51
GLU 22.14 16.42
GLY 1.85 8.21
HIS 2.60 2.32
HYP 0.00 1.54
ILE 4.88 3.74
LEU 9.17 7.51
LYS 7.92 8.22
MET 2.89 3.13
PHE 4.92 3.51
PRO 10.61 6.69
SER 5.37 4.56
TAU 0.00 2.10
THR 4.04 4.01
TYR 3.92 2.29
VAL 6.26 5.04
Fatty acids:
AA 0.18 0.18
EPA 0.02 0.10
DPA 0.08 0.11
DHA 0.05 0.20
n-3 PUFA/ n-6 PUFA 0,10 0,12
a Weight % (wt%) of total protein or fatty acids.
Abbreviations: AA arachidonic acid, Ala Alanine, Arg Arginine, Asp Aspartic acid,
DHA docosahexaenoic acid, DPA docosapentaenoic acid, EPA eicosapentaenoic
acid, FPH fish protein hydrolysate, Glu Glutamate, Gly Glycine, His Histidine,
Hyp Hydroxyproline, Ile Isoleucine, Leu Leucine, Lys Lysine, Met Methionine, Phe
Phenylalanine, Pro Proline, Ser Serine, Tau Taurine, Thr Threonine, Tyr Tyrosine,
Val Valine.
Table 5 Composition of the experimental diets
Ingredients Control (g/kg of diet) FPH (g/kg of diet)
Caseina 238.7 59.7
FPHb - 165.2
Lard 230 226.7
Soy oil 20 20
Cornstarch 179 193
Dyetrose 132 132
Sucrose 100 100
Fiber 50 50
AIN-93G mineral mix 35 35
AIN-93 vitamin mix 10 10
L-Cysteine 3 3
Choline bitartrate 2.5 2.5
tert-Butylhydroquinone 0.014 0.014
Abbreviations: FPH fish protein hydrolysate.
The diets were isoenergetic and isonitrogenous and contained 20 g of protein
per 100 g of diet.
aCasein consisted of 83.8% (w/w) protein and 0.2% fat.
bFPH consisted of 90.8% protein and 2% oil.
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using the triacylglycerol (GPO-PAP) and cholesterol kit
(CHOD-PAP) from Roche Diagnostics, the free fatty
acid (FFA) kit from DiaSys Diagnostic Systems GmbH
(Holzheim, Germany), and the phospholipid kit from
bioMerieux SA (Marcy l’Etoile, France).
Hepatic and WAT fatty acid composition
Total hepatic and WAT fatty acid composition was ana-
lyzed as described previously [22]. The anti-inflammatory
fatty acid index was calculated as ((C22:5n-3 + C22:6n-3 +
C20:3n-6 + C20:5n-3)/C20:4n-6)*100 [34].
Amino acid composition in the diet
The amino acids in the diets were determined after hydroly-
sis in 6M-HCl at 110°C for 22 h and pre-derivatisationwith phenylisothiocyanate according to the method of
Cohen & Strydom [35]. The supernatant was filtered and
amino acids were characterised by a Biochrom 20 plus
amino acid analyser as previously described [29].
Hepatic enzyme activities
The livers were homogenized and fractionated as described
earlier [36]. The activities of carnitine palmitoyltransferase–
II (CPT-II) [37], acyl-CoA oxidase 1 (ACOX1) and fatty
acid synthase (FASN) were measured in the post-nuclear
fraction as described by Skorve et al. [38].
Plasma carnitine composition and cytokines
Free carnitine, short-, medium-, and long-chain acylcar-
nitines, and the precursors for carnitine, trimethyllysine
and γ-butyrobetaine, were analysed in plasma using LC/
MS/MS as described previously [39]. The cytokines INF-γ,
IL-1b, IL-2, IL-4, IL-5, IL-10, IL-12, and GM-CST were
assessed in a 96-well plate assay using custom made eight-
plex kits (Millipore Corp., St. Charles, IL, USA). Cytokines
IL-4, IL-10 and IL-12 did not give a result due to more than
two samples below detection limit. Plasma adiponectin was
measured using a single-plex kit (Millipore). The analysis
was performed on undiluted plasma samples, in an over-
night protocol according to the manufacturer’s recommen-
dations, using the Bio-Plex 200 system (BioRad, Hercules,
CA, USA).
Gene expression analysis
Total cellular RNA was purified from frozen liver sam-
ples, and cDNA was produced as previously described
[40]. Real-time PCR was performed with Sarstedt 384
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USA) on the following genes, using probes and primers
from Applied Biosystems (Foster City, CA, USA):
acetyl-CoA carboxylase alpha (Acaca, Mm01304277_
m1), Acox1 (Mm00443579), trifunctional protein, alpha
subunit (Hadha, Mm00805228_m1), CD36 antigen
(CD36 (Fat), Mm00432403), Cpt1a (Mm00550438),
Cpt2 (Mm00487202), cytochrome P450, family 7,
subfamily A, polypeptide 1 (Cyp7a1, Mm00484152),
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(Hmgc1, Mm00524111), Hmgc2 (Mm00550050), low
density lipoprotein receptor (Ldlr, Mm00440169),
stearoyl-CoA desaturase 1 (Scd1, Mm00772290_m1),
or Solaris qPCR Gene Expression Assays (Thermo
Fisher Scientific Inc.,Waltham, MA, USA): fatty
acid desaturase 1 (Fads1, AX-064722-00), Fads2/Δ6
fatty acid desaturase (AX-049816-00), arylacetamide
deacetylase (Aadac, AX-049058-00). Three different
reference genes were included: 18 s (Kit-FAM-TAMRA
(Reference RT-CKFT-18 s)) from Eurogentec, Belgium,
glyceraldehyde-3-phosphate dehydrogenase (Gapdh,
Mm99999915_g1) from Applied Biosystems, and ribo-
somal protein, large, P0 (Rplp0, Gene ID 11837) from
Thermo Fisher Scientific. NormFinder was used to
evaluate the reference genes, and data normalized to
18 s are presented.Statistical analysis
Data sets were analyzed using Prism Software (Graph-Pad
Software, San Diego, CA) to generate the figures and de-
termine statistical significance. The results are shown as
means with their standard deviations (SD). Student’s t-test
and Mann–Whitney test, for parametric data and non-
parametric data, respectively, were performed to evaluate
statistical differences between the two groups. P-values
< 0.05 were considered significant.
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